Narrow search
Showing 1 - 10 of 20,712
Cover Image
Have pharmaceutical R&D project success rates decreased? : a critical review and new empirical results
Backfisch, Martin - 2017 - Version: 30 October 2017
In the context of the ongoing debate about an innovation crisis in the pharmaceutical industry, we study the success …
Persistent link: https://www.econbiz.de/10011773501
Cover Image
Acquiring R&D projects: who, when, and what? : evidence from antidiabetic drug development
Malek, Jan; Newham, Melissa; Seldeslachts, Jo; … - 2024
This paper analyzes M&A patterns of R&D projects in the antidiabetics industry. For this purpose, we construct a database with all corporate individual antidiabetics R&D projects over the period 1997 - 2017, and add detailed information on firms' technology dimension using patent information,...
Persistent link: https://www.econbiz.de/10014468769
Cover Image
Industrial and organizational mutations in the medical and pharmaceutical sectors impulsed by open innovation during the pandemic
Adatto, Laurent; Aouinait, Camille; Son Thi Kim Le; … - In: Proceedings of the ENTRENOVA - ENTerprise REsearch … 8 (2022) 1, pp. 421-434
largely based on Open Innovation. For that purpose, exploratory case studies will be shown that exemplify the value of … implementing Open Innovation in the pandemic context. These case studies concern the pharmaceutical firm Pfizer, the biotechnology … systematic analysis of articles, scientific documents, and published reports related to the Open Innovation involvement of these …
Persistent link: https://www.econbiz.de/10014308369
Cover Image
Pharmaceutical research strategies
Phlippen, Sandra; Vermeersch, An - 2008
This study analyses 1400 research projects of the top 20 R&D-spending pharmaceuticals to identify the determinants of …
Persistent link: https://www.econbiz.de/10011374419
Cover Image
Pharmaceutical Research Strategies
Phlippen, Sandra; Vermeersch, An - 2014
This study analyses 1400 research projects of the top 20 R&D-spending pharmaceuticals to identify the determinants of …
Persistent link: https://www.econbiz.de/10014047739
Cover Image
How does basic research improve innovation performance in the world's major pharmaceutical firms?
Leten, Bart; Kelchtermans, Stijn; Belderbos, René - In: Industry and innovation 29 (2022) 3, pp. 396-424
Persistent link: https://www.econbiz.de/10013170079
Cover Image
Rushed innovation : evidence from drug licensing
Hermosilla, Manuel - In: Management science : journal of the Institute for … 67 (2021) 1, pp. 257-278
Persistent link: https://www.econbiz.de/10012435267
Cover Image
The risk of innovation : measuring drug clinical development in Brazil
Rocha, Michele de Medeiros; Vieira, Danilo Garbazza; … - In: International journal of business innovation and research 17 (2018) 1, pp. 128-145
Persistent link: https://www.econbiz.de/10011958562
Cover Image
Private versus social incentives for pharmaceutical innovation
González, Paula; Macho-Stadler, Inés; … - 2015
We provide a theoretical framework to contribute to the current debate regarding the tendency of pharmaceutical companies to direct their R&D toward marketing products that are "follow-on" drugs of already existing drugs, rather than toward the development of breakthrough drugs. We construct a...
Persistent link: https://www.econbiz.de/10011406575
Cover Image
Ageing and pharmaceutical innovation
Eisen, Roland; Ilgin, Yasemin - In: The economics of new health technologies : incentives, …, (pp. 149-157). 2009
Persistent link: https://www.econbiz.de/10003915982